Literature DB >> 26980422

Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment.

Mark-Alexander Schwarzbich1, Tilman Schöning2, Martin Cremer1, Katharina Lisenko1, Anthony D Ho1, Matthias Witzens-Harig1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26980422     DOI： 10.3109/10428194.2015.1113274

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017.

Authors:  Haifeng Sun; Li Xue; Yahuan Guo; Jianqiang Du; Kejun Nan; Ming Li
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.